Neurologic Disorders and COVID-19: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
To go to the COVID-19 project topics list, click '''[[COVID-19 Project Topics|here]]'''. | |||
{{CMG}} {{AE}}{{Fs}}, {{RAB}} | {{CMG}} {{AE}}{{Fs}}, {{RAB}} | ||
==Overview== | ==Overview== | ||
Revision as of 14:43, 18 June 2020
To go to the COVID-19 project topics list, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D., Rinky Agnes Botleroo, M.B.B.S.
Overview
Pathophysiology of the Complications in the Nervous System
Mechanism of targetting the Nervous System
Complications in the Central Nervous System
Cerebrovascular Accident/Stroke
- Hemorrhagic
- Ischaemic